切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2015, Vol. 04 ›› Issue (02) : 74 -77. doi: 10.3877/cma.j.issn.2095-3216.2015.02.004

所属专题: 文献

专家论坛

肿瘤相关肾损害的诊断与中西医结合治疗
邢昌赢1,(), 赵传燕1, 陈铭聿1   
  1. 1. 210029 南京医科大学第一附属医院(江苏省人民医院)肾内科
  • 出版日期:2015-04-28
  • 通信作者: 邢昌赢

Treatment of tumors-associated kidney injury with integrated traditional Chinese and western medicine

Changying Xing1,(), Chuanyan Zhao1, Mingyu Chen1   

  1. 1. Nephrology Department, First Hospital Affiliated to Nanjing Medical University (Jiangsu Provincial People′s Hospital), Nanjing 210029, China
  • Published:2015-04-28
  • Corresponding author: Changying Xing
  • About author:
    Corresponding author: Xing Changying, Email:
引用本文:

邢昌赢, 赵传燕, 陈铭聿. 肿瘤相关肾损害的诊断与中西医结合治疗[J/OL]. 中华肾病研究电子杂志, 2015, 04(02): 74-77.

Changying Xing, Chuanyan Zhao, Mingyu Chen. Treatment of tumors-associated kidney injury with integrated traditional Chinese and western medicine[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2015, 04(02): 74-77.

肿瘤与肾脏损害有一定的相关性,肿瘤相关肾损害在肿瘤患者中有着较高的发生率,其病因及发病机制复杂,病理类型及临床表现也表现多样化,应在临床工作中引起足够的重视,以早期诊断,积极治疗,提高患者的生存率。肿瘤相关肾损害传统治疗方案为尽早手术切除肿瘤,结合放化疗治疗,但也可能出现潜在的不良反应。中西医结合治疗是应对肿瘤相关肾损害的较好方略,两者优势互补发挥积极的作用。该文就肿瘤相关肾损害的病因病理、发病机制、诊断及中西医结合治疗进展做一叙述,以期为肿瘤相关肾损害的治疗提供新的思路。

There is a certain association between tumors and kidney injury. Tumors-associated kidney injury has a relatively high incidence in tumors patients with complex etiology and pathogenesis, and diverse pathological types and clinical manifestations, which should be paid sufficient attention to in clinical work for the purpose of early diagnosis, active treatment, and improvement of the survival rate of patients. The traditional treatment regimen for tumors-associated kidney injury is comprised of surgical resection of tumors as early as possible in combination with radiotherapy and chemotherapy, but potential adverse reactions may also take place. Treatment with integrated traditional Chinese and western medicine is a better strategy to cope with tumors-associated kidney injury, as the two can complement each other′s advantages to play active roles. The present paper is a summary on progress of etiology and pathology, pathogenesis, diagnosis, and treatment with integrated traditional Chinese and western medicine for tumors-associated kidney injury in order to provide new ideas for the treatment of tumors-associated kidney injury.

[1]
Cambier JF, Ronco P. Onco-nephrology: glomerular diseases with cancer [J]. Clin J Am Soc Nephrol, 2012, 7(10): 1701-1712.
[2]
Galloway J. Remarks on Hodgkin′s disease [J]. Br Med J, 1922, 2(3234): 1201-1208.
[3]
成小苗,周巧玲. 肿瘤相关性肾损害临床分析[J]. 中国现代医学杂志,2005,15 (11): 1674-1675+1680.
[4]
巴应贵. 恶性肿瘤与肾损害临床分析[J]. 现代预防医学,2013,40(8):1600-1601.
[5]
彭大振. 终末期肾病与恶性肿瘤相关因素探讨 [J].重庆医学,2011,40(1):86-89.
[6]
Touchard G, Preudhom JL. Nephrotic syndrome in chronic lymphocytic leukemia [J]. Clin Nephrol, 1997, 47(2): 131-133.
[7]
Tomoda K, Hamada K, Fukuoka K, et al. Small cell lung cancer associated with nephrotic syndrome: remission after chemotherapy [J]. Nihon Kokyuki Gakkai Zasshi, 1998, 36(6): 541-544.
[8]
周福德,刘玉春.恶性肿瘤相关的肾损害//王海燕.肾脏病学[M].第3版.北京:人民卫生出版社,2008: 1599-1623.
[9]
Tsimberidou AM, Keating MJ. Hyperuricemic syndromes in cancer patients [J]. Contrib Nephrol,2005,147:47-60.
[10]
Nakamura M, Ohishi A, Watanabe R,et al. Adult T-cell leukemia with hypercalcemia-induced metastatic calcification in the lungs due to production of parathyroid hormone-related protein [J]. Intern Med, 2001,40(5):409-413.
[11]
Zinger C, Ben-Itzhak O, Szylman P, et al. Minimal-change nephropathy and malignant thymoma [J]. Am J Nephrol, 1998, 18(1): 61-63.
[12]
Stéphan JL, Deschênes G, Pérel Y, et al. Nephrotic syndrome and Hodgkin disease in children: a report of five cases [J]. EurJ Pediatr, 1997, 156(3): 239-242.
[13]
Sood AK, Dua A, Mahajan A, et al. Minimal change nephrotic syndrome associated with extrarenal neurilemmoma [J]. Nephron, 1997, 75(2): 230-232.
[14]
Burstein DM, Korbet SM, Schwartz MM. Membranous glomerulonephritis and malignancy [J]. Am J Kidney Dis,1993,22(1):5-10.
[15]
Ohtani H, Wakui H, Komatsuda A, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy [J]. Nephrol Dial Transplant,2004, 19(3): 574-579.
[16]
Audard V, Zhang SY, Copie-Bergman C, et al. Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes [J]. Blood, 2010, 115(8): 3756-3762.
[17]
Bernard D, Vindrieux D.PLA2R1: expression and function in cancer [J]. Biochim Biophys Acta, 2014, 1846(1): 40-44.
[18]
Cheuk DK, Chiang AK, Chan GC, et al. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer [J]. Cochrane Database Syst Rev, 2014, 8: CD006945.
[19]
曹晓琳,晁卫红.浅谈中西医结合治疗肿瘤[J].实用中西医结合临床,2008,8(1): 42-43.
[20]
戚伟琳,李勇,陆洪芬,等.红景天抑制乳腺癌血管新生的作用及其机制[J].上海中医药杂志,2007,41(7):62-64.
[21]
刘研新,余彦,王蓓,等.鹿角灵芝胶囊的抗肿瘤活性及对顺铂所致肾损伤的保护作用[J].华西药学杂志,2008,23(5):564-566.
[22]
徐伟刚,钱振萍.升白膏方治疗恶性肿瘤放化疗后白细胞减少症36例临床观察[J].新中医,2013, 45(9):99-101.
[23]
张亚东,解小成,房松.大黄甘草汤治疗抗肿瘤药物性肾损害10例[J].中医杂志,2004,45(4):259-259.
[24]
陈前军,司徒红林,陆德铭,等.乳宁2号对小鼠乳腺癌增殖及细胞凋亡的影响[J]. 新中医,2008,40(6):100-101.
[25]
蒋易容,张紫媛,文集,等.黄葵胶囊治疗IgA肾病疗效和安全性的系统评价[J]. 中国循证医学杂志,2012, 12(9): 1135-1140.
[26]
赵卫东.百令胶囊减轻急性肾损伤的实验研究[J].吉林医学,2011, 32(11):2083-2084.
[27]
聂玲辉,孙升云,伍志勇,等.金水宝胶囊治疗慢性肾功能衰竭的系统评价[J]. 中国实验方剂学杂志,2012,18(11):5-9.
[1] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[3] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[4] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[5] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[6] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[7] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[8] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[9] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[10] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[11] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[14] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[15] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?